GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » OPKO Health Inc (MEX:OPK) » Definitions » EV-to-FCF

OPKO Health (MEX:OPK) EV-to-FCF : -6.40 (As of Dec. 11, 2024)


View and export this data going back to 2011. Start your Free Trial

What is OPKO Health EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, OPKO Health's Enterprise Value is MXN23,408 Mil. OPKO Health's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was MXN-3,656 Mil. Therefore, OPKO Health's EV-to-FCF for today is -6.40.

The historical rank and industry rank for OPKO Health's EV-to-FCF or its related term are showing as below:

MEX:OPK' s EV-to-FCF Range Over the Past 10 Years
Min: -278.55   Med: -14.09   Max: 658.79
Current: -5.78

During the past 13 years, the highest EV-to-FCF of OPKO Health was 658.79. The lowest was -278.55. And the median was -14.09.

MEX:OPK's EV-to-FCF is ranked worse than
100% of 98 companies
in the Medical Diagnostics & Research industry
Industry Median: 27.69 vs MEX:OPK: -5.78

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-11), OPKO Health's stock price is MXN32.72. OPKO Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was MXN-3.153. Therefore, OPKO Health's PE Ratio (TTM) for today is At Loss.


OPKO Health EV-to-FCF Historical Data

The historical data trend for OPKO Health's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OPKO Health EV-to-FCF Chart

OPKO Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.56 495.54 549.70 -9.34 -31.44

OPKO Health Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -34.20 -31.44 -20.08 -12.79 -5.61

Competitive Comparison of OPKO Health's EV-to-FCF

For the Diagnostics & Research subindustry, OPKO Health's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OPKO Health's EV-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, OPKO Health's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where OPKO Health's EV-to-FCF falls into.



OPKO Health EV-to-FCF Calculation

OPKO Health's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=23408.379/-3655.806
=-6.40

OPKO Health's current Enterprise Value is MXN23,408 Mil.
OPKO Health's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-3,656 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OPKO Health  (MEX:OPK) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

OPKO Health's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=32.72/-3.153
=At Loss

OPKO Health's share price for today is MXN32.72.
OPKO Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-3.153.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


OPKO Health EV-to-FCF Related Terms

Thank you for viewing the detailed overview of OPKO Health's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


OPKO Health Business Description

Traded in Other Exchanges
Address
4400 Biscayne Boulevard, Miami, FL, USA, 33137
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.